SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 598 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,413,980 | +5.9% | 6,665 | -4.0% | 0.99% | +10.3% |
| Q2 2023 | $1,335,672 | +46.6% | 6,940 | -2.1% | 0.90% | +30.9% |
| Q4 2022 | $911,136 | -9.0% | 7,090 | -3.1% | 0.69% | -12.1% |
| Q3 2022 | $1,001,000 | -22.6% | 7,315 | 0.0% | 0.78% | -18.7% |
| Q2 2022 | $1,294,000 | +17.5% | 7,315 | -4.3% | 0.96% | +39.8% |
| Q1 2022 | $1,101,000 | -4.8% | 7,640 | +2.1% | 0.69% | -1.6% |
| Q4 2021 | $1,156,000 | -10.2% | 7,480 | -1.3% | 0.70% | -15.1% |
| Q3 2021 | $1,287,000 | +8.7% | 7,580 | +1.1% | 0.82% | +8.0% |
| Q2 2021 | $1,184,000 | +15.6% | 7,498 | +1.7% | 0.76% | +6.0% |
| Q1 2021 | $1,024,000 | -7.9% | 7,373 | +16.1% | 0.72% | -12.3% |
| Q4 2020 | $1,112,000 | – | 6,350 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |